OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Sarnen
State: Obwalden
Zip:
Country: Switzerland
OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Their product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration (AMD). Ophthalmopharma has granted Altacor exclusive rights for its two proprietary therapeutic products for the treatment of glaucoma and dry eye as well as exclusive rights for its EyeBar, a nutraceutical for the prevention of dry AMD and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery (currently known as SOLO).
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2007 | Series A | 1 | - |
Armilar Venture Partners Armilar Venture Partners |
1/2007 | Series A | 1 | - |
Armilar Venture Partners Armilar Venture Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|